{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:21:15Z","timestamp":1790284875000,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s11239-021-02534-z","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T08:04:08Z","timestamp":1628064248000},"page":"20-29","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction"],"prefix":"10.1007","volume":"53","author":[{"given":"Johny","family":"Nicolas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans","family":"Beerkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Andrea","family":"Pivato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanbo","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Giustino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Chiarito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimmer E.","family":"Claessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Nardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Razuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davis","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Camaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Power","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryana","family":"Banashefski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Sweeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman","family":"Baber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Dangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samin K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapoorna","family":"Kini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,4]]},"reference":[{"key":"2534_CR1","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.ijcard.2012.04.011","volume":"167","author":"RF Alcock","year":"2013","unstructured":"Alcock RF, Yong AS, Ng AC, Chow V, Cheruvu C, Aliprandi-Costa B et al (2013) Acute coronary syndrome and stable coronary artery disease: are they so different? Long-term outcomes in a contemporary PCI cohort. Int J Cardiol 167:1343\u20131346","journal-title":"Int J Cardiol"},{"key":"2534_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ahj.2014.05.018","volume":"168","author":"JP Loh","year":"2014","unstructured":"Loh JP, Pendyala LK, Torguson R, Chen F, Satler LF, Pichard AA et al (2014) Incidence and correlates of major bleeding after percutaneous coronary intervention across different clinical presentations. Am Heart J 168:248\u2013255","journal-title":"Am Heart J"},{"key":"2534_CR3","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1016\/j.jacc.2017.02.029","volume":"69","author":"T Palmerini","year":"2017","unstructured":"Palmerini T, Bacchi Reggiani L, Della Riva D, Romanello M, Feres F, Abizaid A et al (2017) Bleeding-related deaths in relation to the duration of dual-antiplatelet therapy after coronary stenting. J Am Coll Cardiol 69:2011\u20132022","journal-title":"J Am Coll Cardiol"},{"key":"2534_CR4","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1016\/j.jacc.2018.09.057","volume":"72","author":"D Capodanno","year":"2018","unstructured":"Capodanno D, Alfonso F, Levine GN, Valgimigli M, Angiolillo DJ (2018) ACC\/AHA versus ESC guidelines on dual antiplatelet therapy: JACC guideline comparison. J Am Coll Cardiol 72:2915\u20132931","journal-title":"J Am Coll Cardiol"},{"key":"2534_CR5","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.jacc.2005.09.060","volume":"47","author":"SV Rao","year":"2006","unstructured":"Rao SV, O\u2019Grady K, Pieper KS, Granger CB, Newby LK, Mahaffey KW et al (2006) A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol 47:809\u2013816","journal-title":"J Am Coll Cardiol"},{"key":"2534_CR6","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jacc.2007.10.040","volume":"51","author":"G Ndrepepa","year":"2008","unstructured":"Ndrepepa G, Berger PB, Mehilli J, Seyfarth M, Neumann FJ, Sch\u00f6mig A et al (2008) Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol 51:690\u2013697","journal-title":"J Am Coll Cardiol"},{"key":"2534_CR7","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jacc.2015.06.1323","volume":"66","author":"P G\u00e9n\u00e9reux","year":"2015","unstructured":"G\u00e9n\u00e9reux P, Giustino G, Witzenbichler B, Weisz G, Stuckey TD, Rinaldi MJ et al (2015) Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary interv, and impact of post-discharge bleeding after percutaneous coronary intervention. J Am Coll Cardiol 66:1036\u20131045","journal-title":"J Am Coll Cardiol"},{"key":"2534_CR8","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.jacc.2015.01.047","volume":"65","author":"DS Kazi","year":"2015","unstructured":"Kazi DS, Leong TK, Chang TI, Solomon MD, Hlatky MA, Go AS (2015) Association of spontaneous bleeding and myocardial infarction with long-term mortality after percutaneous coronary intervention. J Am Coll Cardiol 65:1411\u20131420","journal-title":"J Am Coll Cardiol"},{"key":"2534_CR9","first-page":"804","volume":"38","author":"M Valgimigli","year":"2017","unstructured":"Valgimigli M, Costa F, Lokhnygina Y, Clare RM, Wallentin L, Moliterno DJ et al (2017) Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial. Eur Heart J 38:804\u2013810","journal-title":"Eur Heart J"},{"key":"2534_CR10","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.jacc.2007.02.027","volume":"49","author":"SV Manoukian","year":"2007","unstructured":"Manoukian SV, Feit F, Mehran R, Voeltz MD, Ebrahimi R, Hamon M et al (2007) Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J Am Coll Cardiol 49:1362\u20131368","journal-title":"J Am Coll Cardiol"},{"key":"2534_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1161\/CIRCINTERVENTIONS.108.846741","volume":"2","author":"SK Mehta","year":"2009","unstructured":"Mehta SK, Frutkin AD, Lindsey JB, House JA, Spertus JA, Rao SV et al (2009) Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry. Circ Cardiovasc Interv 2:222\u2013229","journal-title":"Circ Cardiovasc Interv"},{"key":"2534_CR12","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jcin.2011.02.011","volume":"4","author":"R Mehran","year":"2011","unstructured":"Mehran R, Pocock S, Nikolsky E, Dangas GD, Clayton T, Claessen BE et al (2011) Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. JACC Cardiovasc Interv 4:654\u2013664","journal-title":"JACC Cardiovasc Interv"},{"key":"2534_CR13","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.jcin.2013.04.016","volume":"6","author":"SV Rao","year":"2013","unstructured":"Rao SV, McCoy LA, Spertus JA, Krone RJ, Singh M, Fitzgerald S et al (2013) An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry. JACC Cardiovasc Interv 6:897\u2013904","journal-title":"JACC Cardiovasc Interv"},{"key":"2534_CR14","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1161\/CIRCULATIONAHA.119.040167","volume":"140","author":"P Urban","year":"2019","unstructured":"Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D et al (2019) Defining high bleeding risk in patients undergoing percutaneous coronary intervention. Circulation 140:240\u2013261","journal-title":"Circulation"},{"key":"2534_CR15","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1016\/j.jacc.2020.03.070","volume":"75","author":"D Cao","year":"2020","unstructured":"Cao D, Mehran R, Dangas G, Baber U, Sartori S, Chandiramani R et al (2020) Validation of the academic research consortium high bleeding risk definition in contemporary PCI patients. J Am Coll Cardiol 75:2711\u20132722","journal-title":"J Am Coll Cardiol"},{"key":"2534_CR16","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1093\/eurheartj\/ehaa671","volume":"41","author":"N Corpataux","year":"2020","unstructured":"Corpataux N, Spirito A, Gragnano F, Vaisnora L, Galea R, Svab S et al (2020) Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk. Eur Heart J 41:3743\u20133749","journal-title":"Eur Heart J"},{"key":"2534_CR17","first-page":"120","volume":"7","author":"Y Sandoval","year":"2018","unstructured":"Sandoval Y, Apple FS, Smith SW (2018) High-sensitivity cardiac troponin assays and unstable angina. Eur Heart J 7:120\u2013128","journal-title":"Eur Heart J"},{"key":"2534_CR18","unstructured":"National Cardiovascular Data Registry (NCDR) (2011) NCDR CathPCI Registry v4.4. Coder\u2019s Data Dictionary. American College of Cardiology. https:\/\/www.ncdr.com\/WebNCDR\/docs\/default-source\/public-data-collection-documents\/cathpci_v4_codersdictionary_4-4.pdf. Accessed 2 Feb 2021"},{"key":"2534_CR19","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","volume":"60","author":"ECfP Guidelines","year":"2012","unstructured":"Guidelines ECfP, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C et al (2012) Third universal definition of myocardial infarction. J Am Coll Cardiol 60:1581\u20131598","journal-title":"J Am Coll Cardiol"},{"key":"2534_CR20","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1093\/eurheartj\/ehaa671","volume":"41","author":"N Corpataux","year":"2020","unstructured":"Corpataux N, Spirito A, Gragnano F, Vaisnora L, Galea R, Svab S et al (2020) Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk. Eur Heart J 41:3743\u20133749","journal-title":"Eur Heart J"},{"key":"2534_CR21","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.thromres.2020.10.013","volume":"196","author":"A Cordero","year":"2020","unstructured":"Cordero A, Escribano D, Garc\u00eda-Acu\u00f1a JM, Rodriguez-Ma\u00f1ero M, Agra-Bermejo R, Bertomeu-Gonz\u00e1lez V et al (2020) Long-term bleeding risk vs. mortality risk in acute coronary syndrome patients according to the 2019 ARC-HBR definition. Thromb Res 196:516\u2013518","journal-title":"Thromb Res"},{"key":"2534_CR22","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4244\/EIJ-D-20-00052","volume":"16","author":"Y Ueki","year":"2020","unstructured":"Ueki Y, B\u00e4r S, Losdat S, Otsuka T, Zanchin C, Zanchin T et al (2020) Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores. EuroIntervention 16:371\u2013379","journal-title":"EuroIntervention"},{"key":"2534_CR23","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.ijcard.2012.04.011","volume":"167","author":"R Alcock","year":"2013","unstructured":"Alcock R, Yong A, Ng A, Chow V, Cheruvu C, Aliprandi-Costa B et al (2013) Acute coronary syndrome and stable coronary artery disease: are they so different? Long-term outcomes in a contemporary PCI cohort. Int J Cardiol 167:1343\u20131346","journal-title":"Int J Cardiol"},{"key":"2534_CR24","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","volume":"74","author":"MJ Sarnak","year":"2019","unstructured":"Sarnak MJ, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC et al (2019) Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol 74:1823\u20131838","journal-title":"J Am Coll Cardiol"},{"key":"2534_CR25","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/ehjqcco\/qcx047","volume":"4","author":"N Tabata","year":"2018","unstructured":"Tabata N, Sueta D, Yamamoto E, Takashio S, Arima Y, Araki S et al (2018) Outcome of current and history of cancer on the risk of cardiovascular events following percutaneous coronary intervention: a Kumamoto University Malignancy and Atherosclerosis (KUMA) study. Eur Heart J Qual Care Clin Outcomes 4:290\u2013300","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2534_CR26","first-page":"202","volume":"5","author":"T Pilgrim","year":"2012","unstructured":"Pilgrim T, Vetterli F, Kalesan B, Stefanini GG, R\u00e4ber L, Stortecky S et al (2012) The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stents. Circulation 5:202\u2013210","journal-title":"Circulation"},{"key":"2534_CR27","first-page":"63","volume":"53","author":"M Franchini","year":"2007","unstructured":"Franchini M, Veneri D, Lippi G (2007) Inflammation and hemostasis: a bidirectional interaction. Clin Lab 53:63","journal-title":"Clin Lab"},{"key":"2534_CR28","first-page":"5","volume-title":"Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum","author":"A Vieira-de-Abreu","year":"2012","unstructured":"Vieira-de-Abreu A, Campbell RA, Weyrich AS, Zimmerman GA (2012) Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum. Springer, Berlin, pp 5\u201330"},{"key":"2534_CR29","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1161\/CIRCULATIONAHA.117.029870","volume":"136","author":"F Crea","year":"2017","unstructured":"Crea F, Libby P (2017) Acute coronary syndromes: the way forward from mechanisms to precision treatment. Circulation 136:1155\u20131166","journal-title":"Circulation"},{"key":"2534_CR30","first-page":"804","volume":"38","author":"M Valgimigli","year":"2017","unstructured":"Valgimigli M, Costa F, Lokhnygina Y, Clare RM, Wallentin L, Moliterno DJ et al (2017) Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial. Eur Heart J 38:804\u2013810","journal-title":"Eur Heart J"},{"key":"2534_CR31","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1093\/eurheartj\/ehaa670","volume":"41","author":"U Baber","year":"2020","unstructured":"Baber U, Dangas G, Angiolillo DJ, Cohen DJ, Sharma SK, Nicolas J et al (2020) Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS. Eur Heart J 41:3533\u20133545","journal-title":"Eur Heart J"},{"key":"2534_CR32","doi-asserted-by":"crossref","unstructured":"Collet J-P, Thiele H, Barbato E, Barth\u00e9l\u00e9my O, Bauersachs J, Bhatt DL et al, ESC Scientific Document Group (2020) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 42(14):1289\u20131367","DOI":"10.1093\/eurheartj\/ehaa602"},{"key":"2534_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2021.05.012","volume":"337","author":"DL Bhatt","year":"2021","unstructured":"Bhatt DL, Kaski JC, Delaney S, Alasnag M, Andreotti F, Angiolillo DJ et al (2021) Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous intervention. Int J Cardiol 337:1\u20138","journal-title":"Int J Cardiol"},{"key":"2534_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2021.06.025","author":"J Nicolas","year":"2021","unstructured":"Nicolas J, Cao D, Mehran R (2021) Stick to the guidelines or clinical judgment: A toss up? Int J Cardiol. https:\/\/doi.org\/10.1016\/j.ijcard.2021.06.025","journal-title":"Int J Cardiol"},{"key":"2534_CR35","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/j.jacc.2016.02.064","volume":"67","author":"U Baber","year":"2016","unstructured":"Baber U, Mehran R, Giustino G, Cohen DJ, Henry TD, Sartori S et al (2016) Coronary thrombosis and major bleeding after PCI with drug-eluting stents: risk scores from PARIS. J Am Coll Cardiol 67:2224\u20132234","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-021-02534-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-021-02534-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-021-02534-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T14:06:53Z","timestamp":1643206013000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-021-02534-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,4]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["2534"],"URL":"https:\/\/doi.org\/10.1007\/s11239-021-02534-z","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,4]]},"assertion":[{"value":"17 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Usman Baber reports speaker honoraria from AstraZeneca and Boston Scientific. George Dangas reports institutional research grants from Abbott Laboratories, AstraZeneca, Bayer, Boston Scientific, Medtronic, and Daiichi-Sankyo; consultant fees from Biosensors, Boston Scientific, and speaker honoraria from Chiesi. Samin K Sharma reports consulting fees or honoraria from Abbott, Boston Scientific, Abiomed, and Cardiovascular System Inc. Roxana Mehran reports institutional research grants from Abbott Laboratories, Abiomed, Applied Therapeutics, AstraZeneca, Bayer, Beth Israel Deaconess, Bristol-Myers Squibb, CERC, Chiesi, Concept Medical, CSL Behring, DSI, Medtronic, Novartis Pharmaceuticals, OrbusNeich, Zoll; consultant fees from Boston Scientific, Cine-Med Research, Janssen Scientific Affairs, Medscape\/WebMD; consultant fees paid to the institution from Abbott Laboratories, Abiomed (spouse), Bayer (spouse), Beth Israel Deaconess, Bristol-Myers Squibb, CardiaWave, Chiesi, Concept Medical, DSI, Duke University, Idorsia Pharmaceuticals, Medtronic, Novartis, Spectranetics\/Philips\/Volcano Corp; Equity\u2009<\u20091 The other authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present research was approved by the Institutional Review Board and complied with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}